By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Galderma Pharma S.A. 

Tour Europlaza - La Defense 4
20 Avenue Andre Prothin
La Défense  Cedex  92927  France
Phone: 33-1-58-86-45-45 Fax: 33-1-58-86-45-00



Company News
Galderma Pharma S.A. Release: ‘CLEAR’ (IGA 0) Rosacea Patients Experience A Delayed Time To Relapse 9/18/2017 9:51:48 AM
Galderma Pharma S.A.: Combined Use Of Rosacea Therapies Ivermectin 1% Cream And Brimonidine 0.33% Gel Evaluated In MOSAIC Study 9/11/2017 9:23:39 AM
Galderma Pharma S.A. Names Chris Chapman To Oversee Prescription Business Unit 9/8/2017 7:22:47 AM
Chugai Pharma And Galderma Pharma S.A. Announce Global License Agreement For Nemolizumab (CIM331), Novel Biologic For Skin Diseases 7/21/2016 9:48:44 AM
Galderma Pharma S.A. Announces Approval Of Epiduo Gel For The Treatment Of Acne In Japan 7/5/2016 12:31:12 PM
Ipsen (IPN.PA) And Galderma Pharma S.A. Expand Current Distribution Agreement For Dysport In Aesthetic Indications To Some Key Asia-Pacific Territories1 1/6/2016 11:05:13 AM
Galderma Pharma S.A. And Imabiotech Develop A Long-Term Alliance To Access Multimaging Services 11/10/2015 11:17:44 AM
Galderma Pharma S.A., PACER’s National Bullying Prevention Center And #Btproject Hit Musicians Release Powerful, New Song To Discourage Bullying And Inspire Teen Positivity Online 10/8/2014 11:12:09 AM
Galderma Pharma S.A. Announces The Publication Of Positive Results Of The Long-Term Study Of Mirvaso® Gel For Treatment Of Persistent Erythema Of Rosacea 1/29/2014 9:23:41 AM
Galderma Pharma S.A. Announces CEO For North American Operations 1/9/2014 7:14:38 PM